SBK Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
SBK Financial's VRTX Position: Q2 2026 in Review
SBK Financial sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 19 shares — an estimated $8.48K sold.
SBK Financial first reported a position in VRTX in Q1 2026 and held it in 1 quarter. The position peaked at $8.48K in Q1 2026. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- SBK Financial reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- SBK Financial sold 19 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.48K.
- SBK Financial first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 1 quarter.
- SBK Financial's Vertex Pharmaceuticals position peaked at $8.48K in Q1 2026.
- 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.